FOR IMMEDIATE RELEASE
Contact:
Ryan MacDonald, Pro-Choice Washington, Communications Director, ryan@prochoicewashington.org, (206) 624-1990
On Tuesday, March 26, the Supreme Court of the United States (SCOTUS) heard oral arguments on whether the FDA-approved drug, mifepristone, one of two drugs used for medication abortion, should be restricted, even in states like Washington, where it is legally protected.
Mifepristone was approved by the FDA over twenty years ago, and there is an overwhelming body of scientific and medical evidence that shows it is safe and effective.
The journey of mifepristone to the Supreme Court began last year when a conservative, Trump-appointed judge in Texas agreed to hear arguments in the case Alliance for Hippocratic Medicine v. U.S. FDA.
Read the background on how the mifepristone case got here.
Interim Executive Director Sami Alloy released the following statement:
Pro-Choice Washington believes that no one should have their options for essential health care, including medication abortion, limited by politics. Any delay or disruption to abortion care is unacceptable.
Restricting access to this drug will harm patients, particularly patients of color, LGBTQ+ people, immigrants, rural and low-income patients, and people who travel long distances for care.
###
Since becoming an independent organization in October 2021, Pro-Choice Washington has been at the forefront of the reproductive freedom landscape. It has helped to expand and protect abortion access across Washington state. Pro-Choice Washington is the only advocacy organization dedicated solely to reproductive freedom in Washington.
